UBS Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24B | Buy |
|
|||||
|
2025
Q1 | $936M | Buy |
|
|||||
|
2024
Q4 | $827M | Buy |
|
|||||
|
2024
Q3 | $651M | Buy |
|
|||||
|
2024
Q2 | $550M | Sell |
|
|||||
|
2024
Q1 | $533M | Buy |
|
|||||
|
2023
Q4 | $408M | Buy |
|
|||||
|
2023
Q3 | $291M | Sell |
|
|||||
|
2023
Q2 | $309M | Buy |
|
|||||
|
2023
Q1 | $284M | Sell |
|
|||||
|
2022
Q4 | $274M | Buy |
|
|||||
|
2022
Q3 | $200M | Sell |
|
|||||
|
2022
Q2 | $205M | Sell |
|
|||||
|
2022
Q1 | $244M | Buy |
|
|||||
|
2021
Q4 | $226M | Buy |
|
|||||
|
2021
Q3 | $207M | Buy |
|
|||||
|
2021
Q2 | $183M | Buy |
|
|||||
|
2021
Q1 | $130M | Buy |
|
|||||
|
2020
Q4 | $49.6M | Sell |
|
|||||
|
2020
Q3 | $61.4M | Sell |
|
|||||
|
2020
Q2 | $66.6M | Buy |
|
|||||
|
2020
Q1 | $49M | Sell |
|
|||||
|
2019
Q4 | $93.3M | Sell |
|
|||||
|
2019
Q3 | $97M | Buy |
|
|||||
|
2019
Q2 | $99M | Sell |
|
|||||
|
2019
Q1 | $92.1M | Buy |
|
|||||
|
2018
Q4 | $69.2M | Sell |
|
|||||
|
2018
Q3 | $83.2M | Buy |
|
|||||
|
2018
Q2 | $61.2M | Buy |
|
|||||
|
2018
Q1 | $29.6M | Sell |
|
|||||
|
2017
Q4 | $27.5M | Sell |
|
|||||
|
2017
Q3 | $41.2M | Sell |
|
|||||
|
2017
Q2 | $44.1M | Buy |
|
|||||
|
2017
Q1 | $33.7M | Buy |
|
|||||
|
2016
Q4 | $25.1M | Sell |
|
|||||
|
2016
Q3 | $30.4M | Buy |
|
|||||
|
2016
Q2 | $18.2M | Buy |
|
|||||
|
2016
Q1 | $11.7M | Sell |
|
|||||
|
2015
Q4 | $19.6M | Buy |
|
|||||
|
2015
Q3 | $12.5M | Sell |
|
|||||
|
2015
Q2 | $14.7M | Sell |
|
|||||
|
2015
Q1 | $15.3M | Sell |
|
|||||
|
2014
Q4 | $14.7M | Buy |
|